Skip to search formSkip to main contentSkip to account menu

Topical Ointment

Known as: ointments topical, Topical Ointment Dosage Form, Topical Ointment Dose Form 
A ointment intended for administration to a body surface.
National Institutes of Health

Related topics

Related topics

50 relations
Allantoin 0.005 MG/MG Topical Ointment [Sarene]Aluminum Hydroxide 0.00275 MG/MG Topical Ointment [Derma Gran]Augmented Betamethasone 0.0005 MG/MG Topical Ointment [Diprolene]Bacitracin 0.5 UNT/MG / Polymyxin B 10 UNT/MG Topical Ointment
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2016
Review
2016
Crisaborole Topical Ointment, 2%: A Nonsteroidal, Topical, Anti-Inflammatory Phosphodiesterase 4 Inhibitor in Clinical Development for the Treatment of Atopic Dermatitis.
Crisaborole topical ointment, 2% (formerly known as AN2728) is a benzoxaborole, nonsteroidal, topical, anti-inflammatory… 
Highly Cited
2016
Highly Cited
2016
Pharmacokinetic Profile, Safety, and Tolerability of Crisaborole Topical Ointment, 2% in Adolescents with Atopic Dermatitis: An Open‐Label Phase 2a Study
Phosphodiesterase‐4 (PDE4) is an emerging target in treating inflammatory skin diseases. Crisaborole topical ointment, 2% is a… 
Highly Cited
2016
Highly Cited
2016
Crisaborole Topical Ointment, 2% in Patients Ages 2 to 17 Years with Atopic Dermatitis: A Phase 1b, Open‐Label, Maximal‐Use Systemic Exposure Study
Phosphodiesterase‐4 (PDE4) is a promising target in atopic dermatitis (AD) treatment. The pharmacokinetics (PK), safety, and… 
Highly Cited
2015
Highly Cited
2015
A Phase 2, Randomized, Controlled, Dose-Ranging Study Evaluating Crisaborole Topical Ointment, 0.5% and 2% in Adolescents With Mild to Moderate Atopic Dermatitis.
BACKGROUND Crisaborole is a novel, boron-based, small-molecule, topical phosphodiesterase-4 inhibitor in development for the… 
Highly Cited
2014
Highly Cited
2014
Antimicrobial efficacy and wound-healing property of a topical ointment containing nitric-oxide-loaded zeolites.
Topical delivery of nitric oxide (NO) through a wound dressing has the potential to reduce wound infections and improve healing… 
Review
2004
Review
2004
Topical ointment for preventing infection in preterm infants.
BACKGROUND Nosocomial sepsis is a frequent and serious complication of premature infants. The increased susceptibility of ELBW… 
Highly Cited
2004
Highly Cited
2004
Topical tacrolimus 0.1% ointment for refractory skin disease in dermatomyositis: a pilot study
BACKGROUND: Dermatomyositis is an inflammatory disease primarily involving the striated muscles and skin. Muscle disease usually… 
Highly Cited
1999
Highly Cited
1999
Management of partial thickness facial burns (comparison of topical antibiotics and bio-engineered skin substitutes).
Review
1999
Review
1999
A prospective, randomized, double-blind, placebo-controlled trial of glyceryl-trinitrate ointment in the treatment of children with anal fissure.
Highly Cited
1996
Highly Cited
1996
Topical ointment therapy benefits premature infants.
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License